CULLINAN THERAPEUTICS, INC.

PublicCIK: 1789972
CGEMNASDAQ
Location

CAMBRIDGE, MA

ROSENBERG ANTHONY

4
→CULLINAN THERAPEUTICS, INC.
Jun 18, 2026·2d ago
1 txn

MEEK DAVID D.

4
→CULLINAN THERAPEUTICS, INC.
Jun 18, 2026·2d ago
1 txn

WEBSTER STEPHEN W

4
→CULLINAN THERAPEUTICS, INC.
Jun 18, 2026·3d ago
1 txn

ALLEN ANDREW R

4
→CULLINAN THERAPEUTICS, INC.
Jun 18, 2026·3d ago
1 txn

THISTLE MARY

4
→CULLINAN THERAPEUTICS, INC.
Jun 18, 2026·3d ago
1 txn

DOYLE MITTIE

4
→CULLINAN THERAPEUTICS, INC.
Jun 18, 2026·3d ago
1 txn

DOYLE MITTIE

4
→AVALO THERAPEUTICS, INC.
Jun 12, 2026·Jun 12, 2026
1 txn

WEBSTER STEPHEN W

4
→ELOXX PHARMACEUTICALS, INC.
Jun 11, 2026·Jun 11, 2026
1 txn

WIGGINTON JON MARC

4
→SUTRO BIOPHARMA, INC.
Jun 9, 2026·Jun 9, 2026
1 txn

UBS ONCOLOGY IMPACT FUND L.P.

144
→WEREWOLF THERAPEUTICS, INC.
May 28, 2026·May 28, 2026

DOYLE MITTIE

4
→AVALO THERAPEUTICS, INC.
May 26, 2026·May 26, 2026
1 txn

DOYLE MITTIE

4
→AVALO THERAPEUTICS, INC.
May 19, 2026·May 19, 2026
3 txn

BVF PARTNERS L P/IL

4
→XOMA ROYALTY CORP
May 18, 2026·May 18, 2026
8 txn

BVF INC/IL

13F-HR

Holdings

May 15, 2026·May 15, 2026

MPM BIOIMPACT LLC

13F-HR

Holdings

May 15, 2026·May 15, 2026

HUGHES OWEN

4
→ANAPTYSBIO, INC
May 13, 2026·May 13, 2026
1 txn

UBS ONCOLOGY IMPACT FUND L.P.

144
→WEREWOLF THERAPEUTICS, INC.
May 11, 2026·May 11, 2026

DOYLE MITTIE

144
→AVALO THERAPEUTICS, INC.
May 6, 2026·May 6, 2026
-5

MICHAELSON JENNIFER

4
→CULLINAN THERAPEUTICS, INC.
May 6, 2026·May 6, 2026
4 txn

MICHAELSON JENNIFER

144
→CULLINAN THERAPEUTICS, INC.
May 5, 2026·May 5, 2026
-8

LYNX1 CAPITAL MANAGEMENT LP

13F-HR

Holdings

May 4, 2026·May 4, 2026

HUGHES OWEN

4
→XOMA ROYALTY CORP
Apr 22, 2026·Apr 22, 2026
4 txn

TRIGILIO JEFFREY

4
→XOMA ROYALTY CORP
Apr 22, 2026·Apr 22, 2026
2 txn

TRIGILIO JEFFREY

4
→XOMA ROYALTY CORP
Apr 15, 2026·Apr 15, 2026
3 txn

BVF PARTNERS L P/IL

4
→MOONLAKE IMMUNOTHERAPEUTICS
Apr 2, 2026·Apr 2, 2026
6 txn
Page 1 of 30 · 727 total
1